Background and Objectives: Transdermal drug delivery system overcomes the difficulties associated with oral drug delivery and improves therapeutic efficacy and safety of drugs, as it is site-specific due to temporal placement of dosage form on the body that reduces both size and number of doses. Methods: In the present study effort was taken to formulate and evaluate Hydrogel based Transdermal patch of a selected NSAID. Nine formulations of matrix type hydrogel transdermal patches of Aceclofenac were prepared. Results: The pre formulation results obtained for all formulations were satisfactory. The drug-excipients compatibility study was also performed using FTIR and the results established that, there is no significant compatibility in drug and excipients. The physico -chemical properties such as physical appearance, thickness, weight variation, tensile strength, surface pH, swellability, water vapour transmission rate, percentage moisture uptake and folding endurance were evaluated. Conclusion: The in-vitro drug permeation studies of the prepared patches were conducted and finally the optimized formulation was selected.
INTRODUCTION
Most commonly the drugs 1 are given by oral route because of ease of administration but have significant draw backs like low bioavailability due to first pass hepatic metabolism and tendency to produce rapid blood levels that lead to a need for frequent dosing, which can be inconvenient and costly. To overcome these difficulties transdermal drug delivery system has been developed, which improves therapeutic efficacy and safety of drugs, as it is site-specific due to temporal placement of dosage form on the body that reduces both size and number of doses. Transdermal patches deliver the drugs for systemic effects at a predetermined and controlled rate. Through a diffusion process, the drug enters the bloodstream directly through the skin. Since there is high concentration on the patch and low concentration in the blood, the drug will keep diffusing into the blood for a long period of time, maintaining the constant concentration of drug in the blood flow.
Transdermal therapeutic systems 2 are defined as self-contained, discrete dosage forms which when applied to the intact skin, deliver the drug(s) through the skin at controlled rate to the systemic circulation.
Polymer hydrogels 3 are a still new, rapidly developing group of materials, gaining wide applications in many fields, especially pharmacy, medicine and agriculture. The term hydrogel describes three dimensional network structures obtained from a class of synthetic and/or natural polymers which can absorb and retain significant amount of water. It is a permanent or chemical gel stabilized by covalently cross-linked networks. These chemical hydrogels may be prepared either by cross-linking water soluble polymers or by converting hydrophobic polymers in to hydrophilic polymers that are then crosslinked to form a network. Hydrogels can be formulated in a variety of physical forms including slabs, micro particles, nanoparticles, coatings, patches and films.
The characteristic 4 of a successful hydrogelbased transdermal drug delivery patch include painless adhesion to the human body, stability of form and composition, purity, reproducibility, compatibility with active ingredients and high water content. Furthermore because of their high water content, swollen hydrogels can provide a better feeling for the skin in comparison to conventional ointments and patches.
Transdermal drug delivery of NSAIDs 5 is feasible in recent years. The system appears to minimize gastrointestinal side effects and hepatic first pass effect. Furthermore the controlled and sustained release of the active ingredients may be achieved with an enhanced patient compliance. Transdermal delivery of NSAIDs is suitable in case of long term treatment. Aceclofenac 6 is a non-steroidal antiinflammatory prodrug with a short biological half-life of 4 hours and has the adverse effects commonly encountered with the NSAIDS, on oral administration. It is a relatively new drug rather a prodrug of diclofenac and is available in the treatment of arthritis as a conventional dosage form. In the present study attempt is made to develop and optimize a novel hydrogel based transdermal patch 7 using the polymers like PVA and chitosan for the transdermal delivery of Aceclofenac, thereby enhancing the bioavailability of selected drug. Compatibility of the study:
Materials and methods

Materials:
Infra-red spectroscopy:
Infra-red spectroscopy 11 can be used to investigate and predict any possible physicochemical interactions between different components in a formulation and therefore, it can be applied to the selection of suitable, chemically compatible excipients. The aim of the present study was to find out the possible interaction 12 between the selected polymer chitosan and the drug and also to identify the compatibility between the drug and the polymer.
Standardization of Aceclofenac:
Preparation of phosphate buffer P H 7.4 Dissolve 13 2.38 g of disodium hydrogen phosphate, 0.19 g of potassium di hydrogen phosphate and 8 g of sodium chloride in sufficient water and make up to 1000ml. adjust the P H necessary.
Preparation of standard solution
100 mg drug 14 was dissolved in 10 ml methanol and make up to 100 ml with pH 7.4 phosphate buffer. From this 10 ml was withdrawn and makeup to 100 ml with phosphate buffer to get working standard solution. Aliquots 1ml, 2ml, 3ml, 4ml, 5ml, were pipetted out and made up to 50ml with the same buffer solution and absorbance 14 was measured at 273 nm.
Preparation of transdermal patches:
Nine different combinations 15 of matrix type transdermal patches composed of different concentrations of PVA, chitosan and drug were prepared by solvent evaporation method. PVA were accurately weighed and dissolved in 10ml of hot water. Chitosan in 1.5% acetic acid was added to the different formulations and blended well (Table1). Maleic anhydride solution was added drop wise. Then the entire mixture was stirred well for 30 min. Polyethylene glycol was used as plasticizer. The resultant uniform solution was cast on the cylindrical mould, and dried at room temperature for 24hrs. An inverted funnel was placed over the Petridish to prevent fast evaporation of the solvent. After 24hrs, the dried patches were taken out and stored in desiccators for further studies.
Evaluation of transdermal patches:
Physical appearance
All the transdermal films 16 were visually inspected for colour, clarity, flexibility and smoothness.
Thickness
Patch thickness 17 was measured using micrometer screw gauge at three different places of each patch and the mean value was calculated and reported.
Weight uniformity
The films 18 of different batches were dried at 60• C for 4 hours before testing. Five patches from each batch were accurately weighed in a digital balance. The average weight and the standard deviation values were calculated from the individual weights.
Tensile strength
In order to determine the elongation 19 as a tensile strength, the polymeric patch was pulled by means of a pulley system; weights were gradually added to the pan to increase the pulling force till the patch was broken. The
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Swellability
The patches 20 of 2.5 cm² was weighed and put in a petridish containing 10 ml of double distilled water and were allowed to imbibe. Increase in weight of the patch was determined at preset time intervals, until a constant weight was observed.
Folding endurance
Folding endurance 21 of the patches was determined by repeatedly folding one patch at the same place till it either breaks or develops visible cracks on folding number of times manually, which was considered satisfactory to reveal good patch properties. This is important to check the ability of sample to withstand folding. This also gives an indication of brittleness. The number of times the films could be folded at the same place without breaking gives the value of folding endurance.
Surface pH
The patches 22 were allowed to swell by keeping them in contact with 0.5 ml of double distilled water for 1h in glass tubes. The surface pH was then noted by bringing a combined glass electrode near the surface of the patch and allowing it to equilibrate for 1 min.
Water Vapour Transmission (WVT)
Glass vials 23 of equal diameter were used as transmission cells. These transmission cells were washed thoroughly and dried in an oven. About 1gm anhydrous calcium chloride was placed in the cells and the respective polymer films were fixed over the brim. The cells were accurately weighed and kept in a closed desiccator containing saturated solution of potassium chloride to maintain a humidity of 84%. The cells were taken out and weighed after 3, 6, 12, 18, 24 hrs.
Percentage moisture uptake
The weighed films 24 were kept in a desiccator at room temperature for 24 hours and then exposed to 84% RH using a saturated solution of potassium chloride. The films were weighed repeatedly until they showed a constant weight.
Drug entrapment efficiency
The transdermal patches 25 were tested for the content uniformity. A film of size 4 cm 2 was cut and placed in a 100ml volumetric flask. 100ml of a pH 7.4 buffer was added. The contents were stirred in a magnetic stirrer for 24 hrs. After 24hrs, measured out or pipetted out 1ml from this and made volume up to 50 ml by addition of pH 7.4 buffer. The absorbance of the solution was measured against the corresponding blank solution at 273nm.
In-vitro skin permeation studies
The In-vitro skin 26 permeation studies were carried out using dorsal section of full thickness skin from albino rats whose hair had been removed on the previous day using electric clipper. The transdermal patches were firmly pressed on the centre of the rat skin once adhesion to the skin surface had been confirmed; the skin was quickly mounted on the diffusion tube which acted as a donor compartment. 50 ml of phosphate buffer pH 7.4 as a diffusion medium was taken in the beaker which acted as the receptor compartment to maintain the sink condition. The donor compartment was kept in contact with receptor compartment and receptor compartment was stirred magnetically during the study. Sample 1ml 27 was withdrawn and replaced with 1ml of fresh phosphate buffer pH 7.4 at different time intervals. The samples were analysed using UV spectrophotometer at 273 nm to estimate aceclofenac.
Mechanism of release study
To understand 28 the mechanism of release of Aceclofenac from the patches the drug release of optimized drug loaded patches were studied. A graph was plotted with percentage release Vs √time. If linearity is observed, the release mechanism is by Higuchi's diffusion.
Stability study of optimized formulation
Stability study 29 was carried out for optimized patch formulation at 40+2 0 c and 75 + 2% RH humidity chamber. After 15 days and 1 month samples were withdrawn and evaluated 30 for physicochemical properties and in-vitro diffusion study. 
RESULTS AND DISCUSSION
Preformulation of the study:
The pre formulation results obtained for all formulations were satisfactory. Solubility studies were conducted in buffer solutions of pH 7.4. This was conducted to determine appropriate solvent for diffusion. Since in pH 7.4 buffer, solubility of the drug is moderate and the amount is quantifiable in UV range, pH 7.4 buffer was selected as vehicle for further in-vitro diffusion studies.
Calibration curve of aceclofenac:
Calibration curve of Aceclofenac in phosphate buffer is pH 7.4.
Compatibility of studies:
In order to investigate the possible interaction between drug and selected polymers, FT-IR spectroscopy studies were carried out. IR spectrum for pure drug and physical mixture of drug-polymers were obtained and analysed for principle peaks. Drug -excipient interactions play a vital role with respect to release of drug from the formulation amongst others. FTIR techniques have been used here to study the physical and chemical interaction between drug and excipients used. It was observed that there were no changes in these main peaks in IR spectra of mixture of drug and polymers, which show there were no physical interactions because of some bond formation between drug and polymers. 
Evaluation of prepared patches
Prepared patches of combination C 1 -C 9 were subjected to physical evaluation visually and the data shown in table 3.from the physical evaluation data the better appearance and texture showed by the combinations C 6 , C 7 and C 8. The prepared hydrogel transdermal patches of aceclofenac were subjected to physico-chemical evaluation such as thickness and the results were shown in table 4. The data indicates that all combinations (C 1 -C 9 ) measured thickness with minimum standard deviation values. The thickness varied from 0.24 -0.37 mm. The minimum standard deviation values assured that the process used for preparing the drug delivery system is capable of giving reproducible results.
The weight of combinations C 1 -C 9 ranges between 103 -203 mg. The deviation in the weight was within the limits as it confirming by the minimum standard deviation values. It was observed that the variation in weight in different combination which may be due to the variation in polymeric content
The folding endurance of combinations C 1 -C 9 was measured manually and data were shown in the Water vapour transmission study was conducted for combination C 1 -C 9 and the data were shown in the table 4. The result of water vapour transmission study reviled that all the formulation are permeable to water vapour.
The percentage moisture absorption studies were conducted for combinations C 1 -C 9 and the results were shown in table 5. The results indicated that the increase in PVA content increases the percentage moisture absorption. This may be due to the hydrophilicity of PVA. The surface pH of all the combinations was in the range 7.0 -7-3 and hence no skin irritation expected.
The swellability of combinations C 1 -C 9 were measured and the data shown in the table 5.
The swellability of C 1 is 12.902 % which is lower than other combinations. This indicates that the swelling behaviour is greatly influenced by the PVA content. This is because PVA is a water soluble polymer and blending of PVA with Chitosan tends to increase the water uptake due to the increasing of hydrophilic groups. PVA chains entangled with the chitosan chains leading to the formation of hydrogel network.
The percentage of drug content of combinations C 1 -C 9 varied between 61.59 %-93.61 % and it indicated that the combinations C 6 , C 7 and C 8 had good drug containing capability.
In-vitro drug permeation study
The permeation of drug from the dosage form plays important role in transdermal drug delivery and in determining the therapeutic effect of the medication. Upon application of patch, the releases from the dosage form to the skin, diffuses through the layers of skin and is transported away by the blood. The invitro permeation of the drug from patch to the blood was studied at 37 + 0.5 0 C using phosphate buffer pH 7.4 as release medium.
Release of the drug from prepared hydrogel transdermal patches is controlled by the chemical properties of the drug and delivery form, as well as physiological and physicochemical properties of the polymer matrix. The process of drug release in most controlled release devices is governed by diffusion and the polymer matrix has strong influence on the diffusivity as the motion of a small molecule is restricted by the threedimensional network of polymer chains.
The results indicates the cumulative percent of drug permeated from formulations C 1, C 2 , C 3 ,C 4 , C 5 , C 6 , C 7 , C 8 , C 9 The increase of release with increase of PVA content in the patch may be due to the leaching of PVA and pore formation. This leads to an increase in the external film area exposed to the solvent, increased internal porosity and decreased the tortuosity. Also PVA has anti-nucleating effect that converts crystalline drug into high energy amorphous state with improved solubility. The enhancement in solubility of drug increases thermodynamic activity that facilitates permeation of drug across the skin. The rapid leaching of hydrophilic fraction of polymers resulted in the formation of pores and thus leads to the decrease of mean diffusional path length of drug molecules to permeate in dissolution medium.
As combination C 8 shows maximum release it was selected as optimized combination for hydrogel transdermal patch of Aceclofenac.
Kinetics of drug release
The formulation C 8 was selected as best formulation. The drug release data of combinationC 8 was plotted in accordance with Higuchi model. A graph was plotted with % release Vs √time. Linearity is observed, the release mechanism is by Higuchi's diffusion Ideally, controlled drug delivery systems should deliver the drug at a controlled rate over a desired duration. Higuchi tried to relate the drug release rate to the physical constants based on simple laws of diffusion The R 2 value of combination C8 was 0.926 which was more close to unity. This indicates that the drug release from the combination occurs via diffusion process. 
Stability data:
In order to determine the change in physicochemical parameters and in-vitro release profile on storage, stability study was carried out at 40+2 0 c and 75 + 2% RH for 30 days. Sampling time was 15 days and 30 days. The physico-chemical parameter of the optimized formulation was not significantly changed on storage. The in-vitro release profiles shown on figure 7 and 8. The results indicate that the formulation was stable on the required storage condition.
CONCLUSION
The in-vitro drug permeation studies of the prepared patches were conducted and finally the optimized formulation was selected. 
